Hermann Kalhoff
Ruhr University Bochum
31 Papers
139 Citations
Hermann Kalhoff is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Medicine & Metabolic acidosis. The author has an hindex of 13, co-authored 31 publications.
Chat about Author
Papers
Iron intake and iron status in breastfed infants during the first year of life
TL;DR: In this article, the authors performed a secondary analysis of data from a complementary feeding trial, with particular focus on the development of iron status in those infants who were fully breastfed during the first 4 months of life.
101
Nutrition, acid-base status and growth in early childhood.
Hermann Kalhoff,Friedrich Manz +1 more
TL;DR: Modification of the mineral content of a standard preterm formula decreased renal NAE to the low level seen on alimentation with human milk and reduced the incidence of ILMA in preterm and small-for-gestational-age infants to 1 %.
39
Modification of dietary polyunsaturated fatty acids via complementary food enhances n-3 long-chain polyunsaturated fatty acid synthesis in healthy infants: a double blinded randomised controlled trial
Jana Schwartz,Katharina Dube,Wolfgang Sichert-Hellert,Frank Kannenberg,Clemens Kunz,Hermann Kalhoff,Mathilde Kersting +6 more
TL;DR: Feasible dietary modifications of the precursor fatty acid profile via n-3 PUFA-rich vegetable oil favoured n- 3 LC-PUFA synthesis in the complementary feeding period when LC- PUFA intake from breast milk and formula is decreasing.
34
PUFA and LC-PUFA intake during the first year of life: can dietary practice achieve a guideline diet?
TL;DR: LC-PUFAs are predominantly provided by breast milk and formula during the first year of life and consequently decrease when milk consumption decreases, and commercial complementary food might come closer to the Guideline Diet by lowering the n-6/n-3 PUFA ratio through appropriate vegetable oil along with an increase in total fat content up to the legal limit.
32
Alkali therapy versus sodium chloride supplement in low birthweight infants with incipient late metabolic acidosis.
TL;DR: In patients with incipient late metabolic acidosis, NaCl therapy is not as beneficial as NaHCO3 therapy, and 27 patients on NaH CO3 therapy showed an increase in urine pH values, combined with a relatively high gain in body weight and a tendency to increased N‐assimilation.
28